Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ATAI

ATAI Life Sciences NV (ATAI)

ATAI Life Sciences NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATAI
DateTimeSourceHeadlineSymbolCompany
21/05/202407:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
15/05/202421:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATAIATAI Life Sciences NV
15/05/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
15/05/202420:59GlobeNewswire Inc.atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:ATAIATAI Life Sciences NV
24/04/202421:00GlobeNewswire Inc.atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
17/04/202421:00GlobeNewswire Inc.atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of PsychopharmacologyNASDAQ:ATAIATAI Life Sciences NV
28/03/202422:00GlobeNewswire Inc.atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical HighlightsNASDAQ:ATAIATAI Life Sciences NV
27/03/202422:00GlobeNewswire Inc.atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
05/03/202400:00GlobeNewswire Inc.atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01NASDAQ:ATAIATAI Life Sciences NV
29/02/202409:00GlobeNewswire Inc.atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care ConferenceNASDAQ:ATAIATAI Life Sciences NV
14/02/202408:29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATAIATAI Life Sciences NV
07/02/202409:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
07/02/202409:00GlobeNewswire Inc.atai Life Sciences Appoints Anne Johnson as Chief Financial OfficerNASDAQ:ATAIATAI Life Sciences NV
23/01/202423:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
10/01/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
10/01/202408:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
05/01/202400:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
04/01/202423:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
04/01/202423:00GlobeNewswire Inc.atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration PsychedelicsNASDAQ:ATAIATAI Life Sciences NV
03/01/202400:00GlobeNewswire Inc.atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)NASDAQ:ATAIATAI Life Sciences NV
21/11/202301:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
14/11/202323:03GlobeNewswire Inc.atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline HighlightsNASDAQ:ATAIATAI Life Sciences NV
14/10/202307:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
10/10/202323:00PR Newswire (Canada)ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORTNASDAQ:ATAIATAI Life Sciences NV
07/10/202307:05GlobeNewswire Inc.atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro SummitNASDAQ:ATAIATAI Life Sciences NV
03/10/202307:13GlobeNewswire Inc.atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy ParticipantsNASDAQ:ATAIATAI Life Sciences NV
30/09/202306:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
15/09/202306:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
14/09/202322:02GlobeNewswire Inc.atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:ATAIATAI Life Sciences NV
07/09/202306:01GlobeNewswire Inc.atai Life Sciences to Participate in Upcoming September Investor ConferencesNASDAQ:ATAIATAI Life Sciences NV
 Showing the most relevant articles for your search:NASDAQ:ATAI